These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1526395)

  • 21. A comparison of metoclopramide and trimebutine on small bowel motility in humans.
    Grandjouan S; Chaussade S; Couturier D; Thierman-Duffaud D; Henry JF
    Aliment Pharmacol Ther; 1989 Aug; 3(4):387-93. PubMed ID: 2518853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of orally vs. parenterally administrated trimebutine on gastrointestinal and colonic motility in dogs.
    Buéno L; Hondé C; Pascaud X; Junien JL
    Gastroenterol Clin Biol; 1987; 11(3 Pt 2):90B-93B. PubMed ID: 3609630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Colonic motility in humans. Recent physiological, pathophysiological and pharmacological data].
    Jouët P; Coffin B; Cuillerier E; Soulé JC; Flourié B; Lémann M
    Gastroenterol Clin Biol; 2000 Mar; 24(3):284-98. PubMed ID: 10804335
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of trimebutine on colonic propulsion in mice].
    Yamada K; Onoda Y
    J Smooth Muscle Res; 1992 Jun; 28(3):87-93. PubMed ID: 1457960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional dyspepsia: drugs for new (and old) therapeutic targets.
    Cremonini F; Delgado-Aros S; Talley NJ
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):717-33. PubMed ID: 15324710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The involvement of opiate receptors in the effects of trimebutine on intestinal motility in the conscious dog.
    Fioramonti J; Fargeas MJ; Bueno L
    J Pharm Pharmacol; 1984 Sep; 36(9):618-21. PubMed ID: 6149288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome.
    Kountouras J; Chatzopoulos D; Zavos C; Boura P; Venizelos J; Kalis A
    Hepatogastroenterology; 2002; 49(43):193-7. PubMed ID: 11941952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Trimebutine and gastric motility: a tensiographic study].
    Mazzone O; Trovato GM; Mandalà ML; Monello S
    Clin Ter; 1980 Dec; 95(6):629-35. PubMed ID: 7214854
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence for noncholinergic mediation of small intestinal transit in the rat.
    Ruwart MJ; Klepper MS; Rush BD
    J Pharmacol Exp Ther; 1979 Jun; 209(3):462-5. PubMed ID: 439020
    [No Abstract]   [Full Text] [Related]  

  • 30. Choosing a Prokinetic for Your Patient Beyond Metoclopramide.
    Gudsoorkar V; Quigley EMM
    Am J Gastroenterol; 2020 Jan; 115(1):5-8. PubMed ID: 31714358
    [No Abstract]   [Full Text] [Related]  

  • 31. Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial.
    Kountouras J; Gavalas E; Papaefthymiou A; Tsechelidis I; Polyzos SA; Bor S; Diculescu M; Jadallah Κ; Tadeusz M; Karakan T; Bochenek Α; Rozciecha J; Dabrowski P; Sparchez Z; Sezgin O; Gülten M; Farsakh NA; Doulberis M
    Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32650518
    [No Abstract]   [Full Text] [Related]  

  • 32. A trial of trimebutine in spastic colon.
    Lüttecke K
    J Int Med Res; 1978; 6(2):86-8. PubMed ID: 344090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of trimebutine on cholinergic transmission in neurons of the inferior mesenteric ganglion of the rabbit].
    Julé Y
    Gastroenterol Clin Biol; 1987; 11(3 Pt 2):82B-85B. PubMed ID: 3038656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Gastric emptying in elderly patients with cerebral vascular diseases and the effect of trimebutine].
    Inoue K; Kobatake K; Haruma K; Yamanaka H; Fujimura J; Yoshihara M; Sumii K; Kajiyama G
    Nihon Ronen Igakkai Zasshi; 1993 Jan; 30(1):41-5. PubMed ID: 8474227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of dihydroergotamine on digestive motility: electrogastroenterographic control. 1st results].
    Martin A; Moline J; Quentin JC; Levet E; Thillier JL
    Therapie; 1972; 27(5):783-92. PubMed ID: 4651405
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of intraduodenal instillation of trimebutine (Debridat) on interdigestive motility in man].
    Chaussade S; Bérard H; Chanoine F; Guerre J; Couturier D
    Gastroenterol Clin Biol; 1988 Nov; 12(11):864. PubMed ID: 3220236
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pro-kinetic agents. Developments and indications].
    Layer P
    Z Gastroenterol Verh; 1991 Mar; 26():157-8. PubMed ID: 1714133
    [No Abstract]   [Full Text] [Related]  

  • 38. [Accelerator effects of Debridat (trimebutine) on duodenal transit].
    Schang JC; Muller J; Rico E; Grenier JF
    Med Chir Dig; 1982; 11(5):371-4. PubMed ID: 7144287
    [No Abstract]   [Full Text] [Related]  

  • 39. Functional dyspepsia and chronic idiopathic gastric stasis. Role of endogenous opiates.
    Narducci F; Bassotti G; Granata MT; Gaburri M; Farroni F; Palumbo R; Morelli A
    Arch Intern Med; 1986 Apr; 146(4):716-20. PubMed ID: 3963953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostacyclin inhibits gastric emptying and small-intestinal transit in rats and dogs.
    Ruwart MJ; Rush BD
    Gastroenterology; 1984 Aug; 87(2):392-5. PubMed ID: 6376267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.